PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Close Notification

Your cart does not contain any items

Schizophrenia and Psychoses in Later Life

New Perspectives on Treatment, Research, and Policy

Carl I. Cohen Paul D. Meesters Michael Reinhardt

$105.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Cambridge University Press
28 March 2019
By 2050, the number of people aged sixty years and older with schizophrenia is expected to double and affect about 10 million people worldwide. Psychoses are among the most common experiences in later life, with a lifetime risk of 23 percent. As a result, there is a looming crisis in mental health care. Schizophrenia and Psychoses in Later Life is the first major multidisciplinary reference on these important disorders. The book provides guidelines for clinical care, research and policy that are consistent with the emerging paradigmatic changes occurring with respect to schizophrenia in later life. This book features multidisciplinary contributions from experts in the fields of biological psychiatry, social psychiatry, sociology, anthropology, social work, psychology, and neuropsychology that will help professionals to integrate services and attain the best outcomes. The text will guide psychiatrists, psychologists, gerontologists, policymakers, and social scientists in creating innovative new programs to help this underserved and growing population.

By:  
Edited by:   ,
Imprint:   Cambridge University Press
Country of Publication:   United Kingdom
Dimensions:   Height: 233mm,  Width: 156mm,  Spine: 15mm
Weight:   410g
ISBN:   9781108727778
ISBN 10:   1108727778
Pages:   270
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
Part I. Epidemiology, Historical background, Illness Phenomenology, and Diagnostic Issues: 1. Epidemiology of psychotic disorders: methodological issues and empirical findings Robert Sigström and Deborah Gustafson; 2. Epidemiology of schizophrenia: patterns of care for older adults with schizophrenia Donna McAlpine and Ellen McCreedy; 3. Assessment and diagnosis of psychotic symptoms in older adults Michael Reinhardt, Dina Ghoneim, Tessa Murante, Eric Nelson, Paulina Vargas and Shifra Mincer; 4. A comparison of early and late-onset schizophrenia Dina Ghoneim; Part II. Biological, Neurocognitive, and Medical Aspects: 5. Biological changes in older persons with schizophrenia Michael Centorino and Susan Schultz; 6. Cognitive functioning in older adults with schizophrenia Tarek Rajji; 7. Medical issues in older persons with schizophrenia Frank Copeli and Carl I. Cohen; Part III. Outcome and Course: 8. Assessing outcomes in schizophrenia in later life Carl I. Cohen; 9. Positive psychiatry for schizophrenia and other psychotic disorders Graham Eglit, Barton W. Palmer and Dilip V. Jeste; Part IV. Social Functioning and Mood: 10. Social functioning among older community-dwelling persons with schizophrenia Paul D. Meesters; 11. Depression and suicidality in older adults with schizophrenia John Kasckow and Aninditha Vengassery; 12. Community treatment needs Paul D. Meesters; 13. Treatment of schizophrenia and psychoses in older adults: psychopharmacological approaches Subramoniam Madhusoodanan; 14. Model programs and interventions for older adults with schizophrenia Stephen J. Bartels, Peter R. DiMilia and Heather Leutwyler; 15. Changing caregiver needs with increasing age of people with schizophrenia Harriet P. Lefley and Brian R. Ghezelaiagh; 16. Personal accounts of living with schizophrenia across a lifetime: coping strategies and subjective perspectives Tova Band-Winterstein, Hila Avieli and Peli Mushkin; 17. The care of older adults with schizophrenia in developing countries Rujvi Kamat and Samir T. Mukherjee; Part V. Health Policy and Research: Future Directions: 18. Schizophrenia in later life: public policy issues in the United States Michael B. Friedman, Lisa Furst, Paul S. Nestadt, Kimberly A. Williams and Lina Rodriguez; 19. Epilogue: controversies, conjectures, and future directions Carl I. Cohen and Paul D. Meesters.

Carl I. Cohen is SUNY Distinguished Service Professor and Director, Division of Geriatric Psychiatry at State University of New York Downstate Medical Center. He is also the founding director of the Brooklyn Alzheimer's Disease Assistance Center and the Geriatric Psychiatry Fellowship Program. He has authored over 200 articles and three books on topics in mental illness and aging. Paul D. Meesters is a geriatric psychiatrist and tutor in geriatric psychiatry at Friesland Mental Health Services, Leeuwarden, the Netherlands. He has authored over twenty articles and co-edited a book on Neuropsychiatry.

Reviews for Schizophrenia and Psychoses in Later Life: New Perspectives on Treatment, Research, and Policy

Advance praise: 'This book is a unique compendium of the major studies of aging and schizophrenia. In this way, it provides an essential resource for current understanding of the issues involved. The effort itself involves an important and often neglected area of the mental health field. The book covers the two crucial general areas, the nature of the problem of schizophrenia in later life, and the variety of programs possible for its treatment. ... This broad-reaching review reminds care-givers, clinicians, researchers, and community activists of the diversity of 'treatments' that need to be considered and evaluated for more intelligent approaches to care.' John Strauss, Yale University, Connecticut 'This book is a unique compendium of the major studies of aging and schizophrenia. In this way, it provides an essential resource for current understanding of the issues involved. The effort itself involves an important and often neglected area of the mental health field. The book covers the two crucial general areas, the nature of the problem of schizophrenia in later life, and the variety of programs possible for its treatment. ... This broad-reaching review reminds care-givers, clinicians, researchers, and community activists of the diversity of `treatments' that need to be considered and evaluated for more intelligent approaches to care.' John Strauss, Yale University, Connecticut


See Also